Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

被引：0
|
作者：
Mazeron, MC [1 ]
Fillet, AM
Salmon, D
Boukli, N
Houhou, N
Sénéchal, B
Matheron, S
Gozlan, J
Leport, C
Katlama, C
Scieux, C
Imbert, BM
Deny, P
Bour, JB
Freymuth, F
Chanzy, B
Chaput, S
Costagliola, D
机构：
[1] Hop Lariboisiere, Dept Virol, F-75475 Paris, France
[2] Hop La Pitie Salpetriere, CERVI, Dept Virol, Paris, France
[3] Hop St Antoine, Dept Virol, F-75571 Paris, France
[4] Hop Bichat Claude Bernard, Dept Virol, F-75877 Paris, France
[5] Hop St Louis, Dept Virol, Paris, France
[6] Hop Hotel Dieu, Dept Virol, Nantes, France
[7] Hop Avicenne, Dept Virol, F-93009 Bobigny, France
[8] Hop Boccage, Dept Virol, Dijon, France
[9] Hop G Clemenceau, Dept Virol, Caen, France
[10] Hop Michallon, Dept Virol, Grenoble, France
[11] Hop Cochin, Dept Med, F-75674 Paris, France
[12] Hop Bichat Claude Bernard, Dept Infect Dis, F-75877 Paris, France
[13] Hop La Pitie Salpetriere, Dept Infect Dis, Paris, France
[14] INSERM, EMI 0214, Dept Biostat, Paris, France
来源：
AIDS | 2003年 / 17卷 / 05期
关键词：
D O I：
10.1097/00002030-200303280-00029
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：784 / 786
页数：3
相关论文
共 50 条
  • [21] Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy
    Miller, TL
    AIDS, 2003, 17 : S130 - S140
  • [22] Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy
    Patel, V
    Hedayati, SS
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (02): : 109 - 114
  • [23] Prevalence of Metabolic Abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy and Antiretroviral-Naive Patients
    Ramezani, A.
    Mohraz, M.
    Jam, S.
    Banifazl, M.
    Aghakhani, A.
    Eslamifar, A.
    Gachkar, L.
    Yaghmaie, F.
    Nemati, K.
    Velayati, A. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E200 - E200
  • [24] Bacterial disease in HIV-infected patients: The blind spot of highly active antiretroviral therapy?
    Noursadeghi, M
    Ustianowski, A
    Elgalib, A
    Miller, R
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (04) : 532 - 535
  • [25] Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy
    Gourlain, K
    Salmon, D
    Gault, E
    Leport, C
    Katlama, C
    Matheron, S
    Costagliola, D
    Mazeron, MC
    Fillet, AM
    JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (03) : 401 - 407
  • [26] Increased access to the emergency department for coronary heart disease of HIV-infected patients receiving highly active antiretroviral therapy
    Barbaro, G
    ANNALS OF EMERGENCY MEDICINE, 2002, 40 (05) : 530 - 531
  • [27] Pruritus in HIV-infected patients in the era of highly active antiretroviral therapy
    Blanes, Mar
    Belinchon, Isabel
    Betlloch, Isabel
    Portilla, Joaquin
    Reus, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB119 - AB119
  • [28] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
    Bernasconi, E
    Uhr, M
    Magenta, L
    Ranno, A
    Telenti, A
    AIDS, 2001, 15 (08) : 1081 - 1082
  • [29] Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy
    Metsch, Lisa R.
    Bell, Christine
    Pereyra, Margaret
    Cardenas, Gabriel
    Sullivan, Tanisha
    Rodriguez, Allan
    Gooden, Lauren
    Khoury, Nayla
    Kuper, Tamy
    Brewer, Toye
    del Rio, Carlos
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (06) : 1045 - 1049
  • [30] Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy
    Foulon, G
    Wislez, M
    Naccache, JM
    Blanc, FX
    Rabbat, A
    Israël-Biet, D
    Valeyre, D
    Mayaud, C
    Cadranel, J
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 418 - 425
12345